Effect of Methylphenidate on Heart Rate Variability in Children and Adolescents With ADHD: A Systematic Review and
Sílvia H S Gianini1, Andrey A Porto1, Rodrigo D Raimundo2
1São Paulo State University, Marília, Brazil.
Background:
Methylphenidate is a first-line psychostimulant widely prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Although its therapeutic efficacy is well established, concerns remain regarding its potential effects on cardiovascular regulation, particularly on autonomic nervous system balance.
Aims:
To evaluate the effect of methylphenidate on heart rate variability (HRV) in ADHD children and adolescents.
Methods:
Our review included children and adolescents diagnosed with ADHD, studies wherein the intervention group should receive short- or long-term methylphenidate treatment, studies that evaluated participants under conventional treatment except methylphenidate, single or double-blind, non-blind randomized or non-randomized control studies.
Results:
No significant changes were observed in time- and frequency-domain HRV indices, with all outcomes presenting very low certainty of evidence.
Conclusions:
Our results indicate that methylphenidate does not significantly affect resting heart rate HRV in ADHD children and adolescents. The very low certainty of this review's evidence level and high risk of bias warrant further studies to provide stronger scientific and statistical evidence.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...


